Latest 30 News in the Life Sciences Industry
GlobeNewswire
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
18 May 2026
GlobeNewswire
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
18 May 2026
GlobeNewswire
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
18 May 2026
PR Newswire Association LLC.
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
18 May 2026
GlobeNewswire
Carbios announces a change in its governance and the appointment of Benoît Grenot as Chief Executive Officer
18 May 2026
GlobeNewswire
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
17 May 2026
GlobeNewswire
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
17 May 2026
GlobeNewswire
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
16 May 2026
GlobeNewswire
Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
14 May 2026
PR Newswire Association LLC.
Rice Biotech Launch Pad to Sponsor 2nd Edition of the BioElectronic Therapeutics (BETx) Event hosted by the Rice Global Paris Center in June
14 May 2026
GlobeNewswire
Koelis Announces ProMap® Smart Automatic Prostate Contouring Software at AUA 2026
14 May 2026
GlobeNewswire
Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute
14 May 2026
GlobeNewswire
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
14 May 2026
PR Newswire Association LLC.
UroMems Raises $60 Million Strategic Investment from U.S.-Based Ajax Health Fund I
13 May 2026
GlobeNewswire
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13 May 2026
PR Newswire Association LLC.
AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
13 May 2026
PR Newswire Association LLC.
Stimvia Expands Scientific Advisory Board and Commercial Leadership to Advance Global Market Expansion of Flagship URIS® Therapy
13 May 2026
PR Newswire Association LLC.
BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation
08 May 2026
PR Newswire Association LLC.
The Canadian Cancer Society welcomes Ontario's move to lower colorectal cancer screening age to 45
07 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
PR Newswire Association LLC.
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
05 May 2026
PR Newswire Association LLC.
Ortho Development Announces Full Commercial Launch of Trivicta® Hip Stem
04 May 2026
PR Newswire Association LLC.
Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery
30 Apr 2026
PR Newswire Association LLC.
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
30 Apr 2026
Upcoming Events All Events
- May 2026
- Copenhagen: LSX Nordic Congress
- Basel: Pharma Partnering EU Summit 2026
- London: UK Biotech Day